Amrize (AMRZ) Cash & Equivalents (2024 - 2026)

Amrize has disclosed Cash & Equivalents across 3 years of filings, most recently posting $1.1 billion for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $1.1 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (changed N/A YoY), and the FY2025 annual result was $1.9 billion, up 21.26% from the prior year.
• Cash & Equivalents came in at $1.1 billion for Q1 2026 at Amrize, down from $1.9 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.9 billion in Q4 2025 to a low of $601.0 million in Q2 2025.
• The 3-year median for Cash & Equivalents is $1.1 billion (2026), against an average of $1.2 billion.
• Peak annual rise in Cash & Equivalents reached 21.26% in 2025, while the deepest fall reached 21.26% in 2025.
• Amrize's Cash & Equivalents stood at $1.6 billion in 2024, then grew by 21.26% to $1.9 billion in 2025, then plunged by 42.82% to $1.1 billion in 2026.
• The last three Cash & Equivalents figures came in at $1.1 billion (Q1 2026), $1.9 billion (Q4 2025), and $826.0 million (Q3 2025), per Business Quant data.